Judicial Watch • HPV

HPV Archives | Judicial Watch

Documents Obtained by Judicial Watch Reveal 200 Claims Filed with HHS for HPV Vaccine Injuries and Deaths, 49 Compensated 

Documents Reveal that the National Vaccine Injury Compensation Program (VICP) has Paid Out Nearly $6 million in Claims to Victims of Controversial HPV (human papillomavirus) Vaccine, including Families of Two Dead

(Washington, DC) – Judicial Watch announced today that it has received documents from the Department of Health and Human Services (HHS) revealing that its National Vaccine Injury Compensation Program (VICP) has awarded $5,877,710 dollars to 49 victims in claims made against the highly controversial HPV (human papillomavirus) vaccines. To date 200 claims have been filed with VICP, with barely half adjudicated.

The documents came in response to a February 28, 2013, Judicial Watch lawsuit against HHS to force the department to comply with a November 1, 2012, Judicial Watch Freedom of Information Act (FOIA) request (Judicial Watch v. U.S. Department of Health and Human Services (No. 1:13-cv-00197)). On March 12, 2013, The Health Resources and Services Administration (HRSA), an agency of HHS, provided Judicial Watch with documents revealing the following information:

  • Only 49 of the 200 claims filed have been compensated for injury or death caused from the (HPV) vaccine.  Of the 49 compensated claims 47 were for injury caused from (HPV) vaccine the additional 2 claims were for death caused due to the vaccine.
  • 92 (nearly half) of the total 200 claims filed are still pending.  Of those pending claims 87 of the claims against (HPV) vaccine were filed for injury, the remaining 5 claims were filed for death.
  • 59 claims have been dismissed outright by VICP.  The alleged victims were not compensated for their claims against the HPV vaccine.  Of the claims dismissed, 57 were for injuries, 2 were for deaths allegedly caused by the HPV vaccine.
  • The amount awarded to the 49 claims compensated totaled 5,877,710.87 dollars. This amounts to approximately $120,000 per claim.

VICP is a Health and Human Services program that compensates patients who have been adversely affected by certain vaccines. The HHS web site describes the program as a “no-fault alternative to the traditional tort system,” and it covers 16 specific classes of vaccines, including HPV vaccines which were added in 2007.

From its inception, the use of HPV (human papillomavirus) vaccines for sexually transmitted diseases has been hotly disputed.  According to the Annals of Medicine: “At present there are no significant data showing that either Gardasil or Cervarix (GlaxoSmithKline) can prevent any type of cervical cancer since the testing period employed was too short to evaluate long-term benefits of HPV vaccination.”

“This new information from the government shows that the serious safety concerns about the use of Gardasil have been well-founded,” said Judicial Watch President Tom Fitton.  “Public health officials should stop pushing Gardasil on children.”

In addition to obtaining records from the FDA through the agency’s Vaccine Adverse Event Reporting System (VAERS) which has documented thousands of adverse reactions to Gardasil, Judicial Watch also published a special report in 2008 detailing Gardasil’s approval process, side effects, safety concerns and marketing practices.

“The FDA adverse event reports on the HPV vaccine read like a catalog of horrors. Any state or local government now beset by Merck’s lobbying campaigns to mandate this HPV vaccine for young girls ought to take a look at these adverse health reports.”
-Tom Fitton
 On June 8, 2006, the Food and Drug Administration (FDA) approved the drug Gardasil. Gardasil is a vaccine against certain types of human papillomavirus (HPV) which is the primary cause of cervical cancer in women.

  • Several state and local governments have proposed requiring the vaccine for school girls entering the 6th grade.
  • Gardasil is approved for girls as young as nine years old, despite the fact that the youngest girls participating in clinical trials were 11-12 years old.
  • A recent study, published in the New England Journal of Medicine, also questioned the general effectiveness of Gardasil. Additionally, there has not been a chance to study long term side effects of the vaccine.

Judicial Watch, concerned about the rush to market and mandate a drug with possible serious adverse effects, filed its first Freedom of Information Act (FOIA) request on May 9, 2007, and received 1,637 adverse event reports on May 15, 2007. These reports are submitted to the Vaccine Adverse Event Reporting System (VAERS) and used by the FDA to monitor the safety of vaccines.

On August 20, 2007 Judicial Watch filed a request for updated adverse event reports and received 1,824 reports on September, 13 2007. Judicial Watch then filed a complaint against the FDA on October 3, 2007 for failing to fully respond to the May 9, 2007 FOIA request.

Judicial Watch has posted links to the adverse event reports below and continues to monitor VAERS reports submitted to the FDA in relation to Gardasil.

The case was closed in April 2010.

Sign Up for Updates!